FrancophonIA/ELRC3.0 huggingface dataset:
English: Compared with placebo, Orplatna did not increase overall survival time, and the small improvement seen in progression-free survival was not considered relevant in the absence of a benefit in terms of overall survival time.
Slovenian: V primerjavi s placebom se pri jemanju zdravila Orplatna skupni čas preživetja ni podaljšal, kratkotrajno podaljšanje časa, v katerem bolezen ni napredovala, pa ni štelo kot pomembno zaradi odsotnosti koristnih učinkov pri skupnem času preživetja.
English: In addition, the CHMP had concerns over the composite measure of progression-free survival which the Committed noted had not been sufficiently justified.
Slovenian: Poleg tega je imel CHMP pomisleke o kombiniranem ukrepu časa preživetja brez napredovanja bolezni, za katerega je Odbor menil, da ni zadostno utemeljen.
English: The Committee also noted that docetaxel is the standard first-line treatment for hormone-refractory prostate cancer, and that it is likely that most patients who would benefit from Orplatna treatment would have failed docetaxel treatment.
Slovenian: Odbor je tudi opozoril, da je docetaksel standardno zdravljenje prve izbire za hormonsko neodzivnega raka prostate in da je verjetno, da bi se pri večini bolnikov, pri katerih zdravljenje z docetakselom ne bi bilo učinkovito, zdravljenje z zdravilom Orplatna izkazalo za učinkovito.
English: What was Orplatna expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Orplatna uporabljalo?
English: How is Orplatna expected to work?
Slovenian: Kako naj bi zdravilo Orplatna delovalo?
English: Bottle (HDPE)
Slovenian: Steklenica (HDPE)
English: 7.32 g 1 pre-filled syringe
Slovenian: 7,32 g 1 brizga Meso in organi : 26 dni
English: Invented Name Strength Pharmaceutical Form
Slovenian: Jakost Farmacevtska oblika
English: One vial
Slovenian: Karenca
English: 6 vials
Slovenian: 6 stekleničk Meso in organi: 26 dni
English: (Invented) name Strength Pharmaceutical Form
Slovenian: Izmišljeno ime Jakost
English: MA (EU) number
Slovenian: Številka EU dovoljenja za promet
English: France considered that the dosing regime of the product is not correct.
Slovenian: Francija meni, da urnik odmerjanja zdravila ni pravilen.
English: It considered this may lead to lack of efficacy and furthering resistance development in target pathogens, which could possibly lead to risks to human health where zoonotic bacteria are concerned.
Slovenian: To lahko privede do pomanjkljive učinkovitosti in nadaljnjega razvoja odpornosti ciljnih patogenih organizmov, kar bi lahko v primeru zoonoznih bakterij povzročilo tudi tveganje za človeško zdravje.
English: The CVMP started the referral procedure during its meeting of 6-8 November 2007.
Slovenian: Odbor CVMP je s postopkom začel dne 6. novembra 2007.
English: BACKGROUND INFORMATION
Slovenian: ZNANSTVENI ZAKLJUČKI
English: CVMP agreed that Equibactin vet. proved to be essentially similar to reference product Tribrissen Oral Paste.
Slovenian: Zdravilo Equibactin vet. peroralna pasta se je izkazalo za bistveno podobno referenčnemu zdravilu Tribrissen peroralna pasta.
English: European Medicines Agency Veterinary Medicines and Inspections
Slovenian: Predlagatelj ali imetnik dovoljenja za promet z zdravilom
English: The matter was referred to the Co-ordination Group for Mutual Recognition and Decentralised Procedures CMD(v) and subsequently to the CVMP.
Slovenian: fazo ocenjevanja in napotitvenega postopka v CMD(v) za tem.
English: In response to the questions, the applicant submitted the dossier and argued on the basis of a comparison of compositions and pharmacokinetic data, that there are no differences between Equibactin vet. and the reference product that would justify different conclusions on the safety and efficacy for the two products.
Slovenian: V odgovor na 2. vprašanje je predlagatelj poudaril, da ni nikakršnih razlik, ki bi utemeljile različne zaključke o varnosti in učinkovitosti obeh zdravil.
English: The Marketing Authorisation Holder was requested to provide a copy of the dossier and, in view of the concerns raised by France, to indicate and to substantiate where necessary, any differences between Equibactin vet. and the reference product Tribrissen Oral Paste that could justify different conclusions on the safety or efficacy.
Slovenian: Glede na zadržke, ki jih je imela Francija, prikaz in po potrebi utemeljitev morebitnih razlik med zdravilom Equibactin vet. (333 mg/g + 67 mg/g) peroralna pasta za konje in referenčnim zdravilom Tribrissen peroralna pasta (odobreno na Nizozemskem), s katerimi bi lahko utemeljili različne zaključke glede varnosti ali učinkovitosti obeh zdravil.
English: Staphylococcus aureus.
Slovenian: Willeskop 212
English: Being aware of a referral ongoing at the time under Article 35 of Directive 2001/82/EC, as amended, for reference product Tribrissen Oral Paste, CVMP recommended that the outcome of that referral procedure (EMEA/V/023) should apply to the marketing authorisation of Equibactin vet.
Slovenian: Priporoča se uporaba zdravila Equibactin vet. peroralna pasta, v skladu z rezultatom napotitvenega postopka EMEA/V/023 iz člena 35 Direktive 2001/82/ES, kakor je bila spremenjena, kot različice referenčnega zdravila Tribrissen peroralna pasta, odobrenega na Nizozemskem.
English: Equibactin vet. is a paste for oral use containing trimethoprim and sulfadiazine as active ingredients and is indicated for treatment of infections in horses caused by bacteria sensitive to the combination of trimethoprim and sulfadiazine, particularly:
Slovenian: Glede na enako sestavo, kar zadeva zdravilni učinkovini trimetoprim in sulfadiazin, enako farmacevtsko obliko in dokazano biološko enakovrednost med zdravilom Equibactin vet. peroralna pasta in zdravilom Tribrissen peroralna pasta za učinkovini trimetoprim in sulfadiazin, se zdravili obravnavata za bistveno podobni.
English: COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
Slovenian: Izmišljeno ime zdravila Farmacevtska oblika
English: France could not agree to the granting of a marketing authorisation as it considered there were potential serious risks to animal health.
Slovenian: Zadržki, ki jih je imela Francija, ne bi smeli preprečiti odobritve dovoljenja za promet z zdravilom Equibactin vet. peroralna pasta.
English: London, August 2008 EMEA/455918/2008
Slovenian: 3421 GW Oudewater Nizozemska
English: OPINION FOLLOWING AN ARTICLE 33 (4) REFERRAL FOR EQUIBACTIN VET.
Slovenian: Zadeva je bila skladno s členom 33(4) Direktive Sveta 2001/82/ES, kakor je bila spremenjena, napotena na Odbor za zdravila za uporabo v veterinarski medicini (CVMP).
English: The CVMP Opinion was adopted on 12 December 2007 and the subsequent Commission Decision on 3 March 2008.
Slovenian: Dne 16. novembra 2007 je Odbor od imetnikov dovoljenja za promet prejel odgovore na vprašanja, zato so z merjenjem časa nadaljevali.
English: • Urogenital infections associated with beta-hemolytic streptococci;
Slovenian: 333,3 mg/g sulfadiazina in 66,7 mg/g trimetoprima.
English: Therefore the same conclusions on efficacy and safety apply equally to both products and the objections raised by France should not prevent the granting of a marketing authorisation.
Slovenian: Posledično za obe zdravili veljajo enaki zaključki o učinkovitosti in varnosti.
English: Activity in cell culture and/or biochemical studies
Slovenian: Aktivnost v celični kulturi in/ali biokemičnih študijah
English: − Your urine is darker than normal
Slovenian: − je vaš urin temnejši kot običajno;
English: Examples are provided below.
Slovenian: Primeri so navedeni spodaj.
English: Keep the medicine pack with you so that you can easily describe what you have taken.
Slovenian: Škatlo z zdravilom vzemite s seboj, tako da boste lahko opisali, kaj ste zaužili.
English: Efficacy analyses performed on other parts of the study demonstrated similarly high SVR12 rates.
Slovenian: Analize učinkovitosti izvedene na drugih delih študije so prikazale podobno visoke deleže SVR12.
English: The majority of these ALT elevations were transient and assessed as drug-related.
Slovenian: Večina teh zvišanj ALT je bila prehodnih in so jih ocenili kot povezane z zdravilom.
English: There is no pharmacokinetic information in patients >75 years.
Slovenian: Ni farmakokinetičnih podatkov o bolnikih >75 let.
English: Drug interaction studies have only been performed in adults.
Slovenian: Študije medsebojnega delovanja zdravil so bile izvedene le pri odraslih.
English: Durability of response
Slovenian: Trajnost odziva
English: SAPPHIRE I and II
Slovenian: SAPPHIRE I in II
English: It is very important that you complete the full course of treatment.
Slovenian: da v celoti zaključite postopek zdravljenja.
English: Do not take Viekirax if any of the above apply to you.
Slovenian: Ne jemljite zdravila Viekirax, če kar koli od zgoraj navedenega velja za vas.
English: Caution is advised due to the expected increase in paritaprevir exposures.
Slovenian: Previdnost je priporočljiva zaradi pričakovanega povečanja izpostavljenosti paritaprevirju.
English: • Decide what other medicines you should take with Viekirax and for how long.
Slovenian: • odloči, katera druga zdravila morate jemati z zdravilom Viekirax in kako dolgo;
English: You will take Viekirax for 8, 12 or 24 weeks.
Slovenian: Zdravilo Viekirax boste jemali 8, 12 ali 24 tednov.
English: • If you are allergic to ombitasvir, paritaprevir, ritonavir, or any of the other ingredients of this medicine (listed in section 6).
Slovenian: • Če ste alergični na ombitasvir, paritaprevir, ritonavir ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Raltegravir exposure is substantially increased (2-fold).
Slovenian: Izpostavljenost raltegravirju se bistveno poveča (2-krat).
English: See also Table 2 for specific advice on raltegravir and buprenorphine, which have been evaluated in drug interaction studies.
Slovenian: Glejte tudi preglednico 2 za specifičen nasvet o raltegravirju in buprenorfinu, ki sta bila ocenjena v študijah medsebojnega delovanja zdravil.
English: Limited data in patients with endstage renal disease indicate no clinically significant changes in exposure also in this patient group.
Slovenian: Omejeni podatki pri bolnikih s končno ledvično odpovedjo ne kažejo nobenih klinično pomembnih sprememb pri izpostavitvi tudi pri tej skupini bolnikov.
English: 95% CIa F0-F1
Slovenian: 95% IZa F0-F1
English: Do not stop taking Viekirax unless your doctor tells you to.
Slovenian: Ne prenehajte jemati zdravila Viekirax, razen če vam to naroči zdravnik.
English: Caution is advised.
Slovenian: Priporočljiva je previdnost.
English: Summary of study design
Slovenian: Povzetek načrta študije
English: The ritonavir exposures were comparable between Asians and non-Asians.
Slovenian: Izpostavljenosti ritonavirju so bile primerljive med aziati in preiskovanci, ki niso bili aziati.
English: Viekirax tablets are packed into foil blisters containing 2 tablets.
Slovenian: Tablete zdravila Viekirax so pakirane v pretisne omote, ki vsebujejo 2 tableti.
English: Pharmacokinetic steady state for the combination is achieved after approximately 12 days of dosing.
Slovenian: Farmakokinetično stanje dinamičnega ravnovesja za kombinacijo je doseženo po približno 12 dneh uporabe.
English: The effects of Viekirax during pregnancy are not known.
Slovenian: Učinki zdravila Viekirax med nosečnostjo niso znani.
English: Among these subjects, the positive predictive value of SVR12 on SVR24 was 99.8%.
Slovenian: Pri teh preiskovancih je bila pozitivna napovedna vrednost SVR12 za SVR24 99,8 %.
English: Concerning cross-resistance, see also section 5.1.
Slovenian: Glede navzkrižne odpornosti glejte tudi poglavje 5.1.
English: The film-coated tablets are for oral use.
Slovenian: Filmsko obložene tablete so namenjene za peroralno uporabo.
English: • If you or your partner becomes pregnant during treatment with Viekirax and ribavirin or in the months that follow, you must contact your doctor immediately.
Slovenian: • Če vi ali vaša partnerica zanosi med zdravljenjem z zdravilom Viekirax in ribavirinom ali v naslednjih mesecih po zdravljenju, takoj obvestite svojega zdravnika.
English: • More than 12 hours until your next dose - take the missed dose with food as soon as possible.
Slovenian: • več kot 12 ur do naslednjega odmerka - vzemite pozabljeni odmerek s hrano v najkrajšem možnem času;
English: Viekirax has no or negligible influence on the ability to drive and use machines.
Slovenian: Zdravilo Viekirax nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
English: SVR12 % (n/N) Outcome for subjects without SVR12
Slovenian: SVR12 % (n/N) Izid pri preiskovancih brez SVR12
English: Frequencies are defined as follows: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) or very rare (<1/10,000).
Slovenian: Opredelitev pogostnosti je: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10,000 do
English: Your doctor will talk with you about which of these medicines to take with Viekirax.
Slovenian: Zdravnik se bo z vami pogovoril o tem, katero od teh dveh zdravil boste jemali z zdravilom Viekirax.
English: Medicinal products transported by the OATP family and OCT1
Slovenian: Zdravila, ki se prenašajo z družino OATP in OCT1
English: In clinical studies
Slovenian: V kliničnih študijah
English: NA Decrease amlodipine dose by 50% and monitor patients for clinical effects.
Slovenian: Zmanjšanje odmerka amlodipina za 50 % in klinična kontrola bolnika.
English: Concomitant use of fluticasone can increase systemic exposures of fluticasone.
Slovenian: Sočasna uporaba flutikazona lahko poveča sistemsko izpostavljenost flutikonazonu.
English: It is an antiviral medicine used to treat adults with chronic (long-term) hepatitis C (an infectious disease that affects the liver, caused by the hepatitis C virus).
Slovenian: To je protivirusno zdravilo, ki se uporablja za zdravljenje odraslih s kroničnim (dolgotrajnim) hepatitisom C (nalezljiva bolezen, ki prizadane jetra in jo povzroča virus hepatitisa C).
English: • Take the tablets in the morning with food.
Slovenian: • Tablete vzemite zjutraj s hrano.
English: • Less than 12 hours until your next dose - do not take the missed dose, take your next dose as usual with food.
Slovenian: • manj kot 12 ur do naslednjega odmerka - ne vzemite pozabljenega odmerka, ampak vzemite naslednji odmerek kot običajno s hrano.
English: − Notice yellowing of your skin or eyes
Slovenian: − opazite porumenelost kože ali oči;
English: • indinavir, lopinavir/ritonavir, saquinavir, tipranavir,
Slovenian: • indinavir, lopinavir/ritonavir, sakvinavir, tipranavir,
English: For a general comment on treatment of HIV co-infected patients, including a discussion on different antiretroviral regimens that may be used, please see section 4.4 (Treatment of HIV co-infected patients).
Slovenian: Za splošen komentar o zdravljenju bolnikov s sočasno okužbo z virusom HIV, vključno z diskusijo o različnih protivirusnih zdravljenjih, ki jih je možno uporabiti, glejte poglavje 4.4 (Zdravljenje bolnikov, sočasno okuženih s HIV).
English: Malformations at low incidence were observed mainly in the eyes (microphthalmia) and teeth (absent incisors).
Slovenian: Malformacije, katerih incidenca je bila majhna, so opažali predvsem na očeh (mikroftalmija) in zobeh (odsotnost sekalcev).
English: HCV genotype (GT)
Slovenian: HCV genotip (GT)
English: Stop taking Viekirax and talk to your doctor or get medical help immediately if any of the following occur:
Slovenian: Prenehajte z jemanjem zdravila Viekirax in se pogovorite z zdravnikom ali si nemudoma priskrbite zdravniško pomoč, če se pojavi kaj od naslednjega:
English: The efficacy of Viekirax has not been established in patients with HCV genotypes 2, 3, 5 and 6; therefore Viekirax should not be used to treat patients infected with these genotypes.
Slovenian: Učinkovitost zdravila Viekirax ni bila dokazana pri bolnikih, okuženih s HCV genotipov 2, 3, 5 in 6, zato se zdravila Viekirax ne sme uporabljati za zdravljenje bolnikov, okuženih s temi genotipi.
English: If the combination is used, repeated ECG-monitoring should be done, see section 4.4.
Slovenian: Če je takšna kombinacija uporabljena, je treba ponavljati kontrole EKG, glejte poglavje 4.4.
English: Take two tablets in the morning.
Slovenian: Vzemite dve tableti zjutraj.
English: Cmax (ng/ml) (% CV)
Slovenian: Cmax (ng/ml) (% KV)
English: PEARL I was conducted in the US and Europe, M12536 in Japan.
Slovenian: ZDA in Evropi, M12-536 pa na Japonskem.
English: It is very important that you also read the package leaflets for the other antiviral medicines that you take with Viekirax.
Slovenian: Pomembno je, da preberete tudi navodila za uporabo drugih protivirusnih zdravil, ki jih jemljete z zdravilom Viekirax.
English: The recommended dose is two tablets taken together in the morning.
Slovenian: Priporočeni odmerek je dve tableti, ki ju vzamete zjutraj.
English: • Feeling weak or lack of energy (asthenia)
Slovenian: • občutek šibkosti ali pomanjkanja energije (astenija)
English: The combined action of the three active substances stops the hepatitis C virus from multiplying and infecting new cells, thus clearing the virus from your blood over a period of time.
Slovenian: Kombinirano delovanje treh učinkovin ustavi razmnoževanje virusa hepatitisa C in okužbo novih celic ter v določenem časovnem obdobju odstrani virus iz krvi.
English: AUC (ng*hr/ml) (% CV)
Slovenian: AUC (ng*hr/ml) (% KV)
English: There are some medicines you must not take with Viekirax see the previous table “Medicines you must not take with Viekirax”.
Slovenian: Obstajajo nekatera zdravila, ki jih ne smete jemati z zdravilom Viekirax - glejte prejšnjo preglednico “Zdravila, ki jih ne smete jemati z zdravilom Viekirax”.
English: for many different conditions including serious illnesses and allergies trazodone for anxiety and depression warfarin and other similar medicines called vitamin K antagonists*
Slovenian: pri številnih različnih stanjih vključno s hudimi boleznimi in alergijami trazodon pri tesnobi in depresiji varfarin in druga podobna zdravila imenovana antagonisti vitamina K*
English: If clinically indicated, higher doses of esomeprazole/lansoprazole may be needed.
Slovenian: Če je klinično indicirano, bodo morda potrebni večji odmerki esomeprazola/lansopr azola.
English: ** When assessing severity of liver disease using non-invasive methods, a combination of blood biomarkers or the combination of liver stiffness measurement and a blood test improves accuracy and should be undertaken prior to 8 week treatment in all patients with moderate fibrosis.
Slovenian: ** Pri oceni resnosti bolezni jeter z uporabo neinvazivnih metod kombinacija krvnih biomarkerjev ali kombinacija meritev togosti jeter in krvnega testa poveča natančnost in jo je potrebno izvesti pred 8-tedenskim zdravljenjem pri vseh bolnikih z zmerno fibrozo.
English: 10 kg change in body weight from 76 kg (median weight in the Phase 3 studies) would results in <10% change in ombitasvir exposures, and no change in paritaprevir exposures.
Slovenian: Sprememba telesne mase za10 kg od 76 kg (mediana telesna masa v študijah 3. faze) bi imela za posledico < 10 % spremembo izpostavljenosti ombitasvirju in nobene spremembe izpostavljenosti paritaprevirju.
English: Therefore, the interaction profile of the compounds must be considered as a combination.
Slovenian: Zato je treba interakcijske značilnosti obeh spojin upoštevati skupaj.
English: • sildenafil (when used for the treatment of pulmonary arterial hypertension)
Slovenian: • sildenafil (če je uporabljen za zdravljenje pljučne arterijske hipertenzije)
English: Body weight is not a significant predictor of ritonavir exposures.
Slovenian: Telesna masa ni pomemben napovednik izpostavljenosti ritonavirju.
English: Pharmacotherapeutic group: Antivirals for systemic use; direct-acting antivirals, ATC code: J05AP53
Slovenian: Farmakoterapevtska skupina: Zdravila za sistemsko zdravljenje virusnih infekcij, zdravila z direktnim delovanjem na viruse; oznaka ATC: J05AP53
English: Haemoglobin <100-80 g/L (grade 2) <80-65 g/L (grade 3) <65 g/L (Grade 4)
Slovenian: Hemoglobin < 100-80 g/l (2. stopnja) < 80-65 g/l (3. stopnja) < 65 g/l (4. stopnja)
English: Ritonavir acts as a ‘booster' to prolong the action of paritaprevir in the body.
Slovenian: Ritonavir deluje kot ‘ojačevalec', ki podaljša delovanje paritaprevirja v telesu.
English: Examples of contraindicated strong or moderate enzyme inducers are provided below.
Slovenian: Primeri kontraindiciranih močnih ali zmernih induktorjev encimov so navedeni spodaj.
English: • Treatment should be discontinued in patients who develop evidence of hepatic decompensation.
Slovenian: • zdravljenje je treba prekiniti pri bolnikih, pri katerih so se pojavili znaki dekompenzacije jeter.
English: Ombitasvir and paritaprevir block two proteins essential for the virus to multiply.
Slovenian: Ombitasvir in paritaprevir zavreta dve beljakovini, ki sta nujno potrebni za razmnoževanje virusa.
English: • cisapride
Slovenian: • cisaprid
English: The blood to plasma concentration ratios in humans ranged from 0.6 to 0.8 indicating that ombitasvir and paritaprevir were preferentially distributed in the plasma compartment of whole blood.
Slovenian: Razmerje med koncentracijo v krvi in plazmi je pri človeku segalo od 0,6 do 0,8; to kaže, da se ombitasvir in paritaprevir prednostno porazdelita v plazemskem razdelku polne krvi.
English: With RBV n/N % n/N % n/N %
Slovenian: Z RBV n/N % n/N % n/N %
English: At least 5 minor metabolites of paritaprevir have been identified in circulation that accounted for approximately 10% of plasma radioactivity.
Slovenian: V obtoku so ugotovili vsaj 5 manjših presnovkov paritaprevirja, na račun katerih je šlo približno 10 % radioaktivnosti v plazmi.
English: Your doctor will test your blood before, during and after your treatment with Viekirax.
Slovenian: Vaš zdravnik bo opravil krvne preiskave pred in med zdravljenjem z zdravilom Viekirax ter po njem.
English: Use with tacrolimus, sirolimus and everolimus
Slovenian: Uporaba s takrolimusom, sirolimusom in everolimusom
English: Do not use the medicine after the expiry date which is stated on the carton after ‘EXP'.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli poleg oznake ʻEXP'.
English: -have diabetes.
Slovenian: - imate sladkorno bolezen.
English: 16 Weeks
Slovenian: 16 tednov
English: PEARL II, III, and IV TURQUOISE II (subjects with cirrhosis)
Slovenian: PEARL II, III in IV TURQUOISE II (preiskovanci s cirozo)
English: Treatment with Viekirax should be initiated and monitored by a physician experienced in the management of chronic hepatitis C.
Slovenian: Zdravljenje z zdravilom Viekirax mora uvesti in nadzirati zdravnik, ki ima izkušnje z vodenjem kroničnega hepatitisa C.
English: In case a dose of Viekirax is missed, the prescribed dose can be taken within 12 hours.
Slovenian: Če bolnik izpusti odmerek zdravila Viekirax, lahko predpisani odmerek vzame v 12 urah.
English: This is because serious or lifethreatening effects can occur when Viekirax is taken with these medicines.
Slovenian: To pa zato, ker se lahko pojavijo resni ali življenje ogrožajoči učinki, če se zdravilo Viekirax jemlje sočasno s temi zdravili.
English: Mechanism: Unknown
Slovenian: Mehanizem: ni znan
English: • lurasidone
Slovenian: • lurasidon
English: Contraceptive medicines that contain ethinyloestradiol cannot be used in combination with Viekirax.
Slovenian: Zdravila za kontracepcijo, ki vsebujejo etinilestradiol, se ne smejo uporabljati v kombinaciji z zdravilom Viekirax.
English: Contents of the pack and other information What Viekirax contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Viekirax
English: If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Viekirax.
Slovenian: Če kar koli od zgoraj navedenega velja za vas (ali če ste negotovi), se posvetujte z zdravnikom ali farmacevtom, preden vzamete zdravilo Viekirax.
English: AFP* < 20 ng/mL, platelets ≥ 90 x 109/L, AND albumin ≥ 35 g/L prior to treatment
Slovenian: AFP* < 20 ng/ml, trombociti ≥ 90 x 109/l, IN albumin ≥ 35 g/l pred zdravljenjem